Ładuje się......
New Receptor Targets for Medical Therapy in Irritable Bowel Syndrome
BACKGROUND: Despite setbacks to the approval of new medications for the treatment of irritable bowel syndrome, interim guidelines on endpoints for IBS trials have enhanced interest as new targets for medical therapy are proposed based on novel mechanisms or chemical entities. AIM: To review the appr...
Zapisane w:
| 1. autor: | |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
2010
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2896496/ https://ncbi.nlm.nih.gov/pubmed/19785622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2036.2009.04153.x |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|